Pulmonary tuberculosis infection and CMV reactivation following daratumumab treatment in a patient with relapsed plasmablastic lymphoma

Plasmablastic lymphoma (PBL) is an aggressive lymphoma with limited treatment strategies. Tuberculosis (TB) infection poses a high risk for patients with hematologic malignancies, especially those treated with immune agents but were never reported post-daratumumab treatment. Herein, we reported a TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wenyue, Wan, Yuling, Yang, Xingcheng, Huang, Wei, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742111/
https://www.ncbi.nlm.nih.gov/pubmed/36518236
http://dx.doi.org/10.1097/BS9.0000000000000134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742111/
https://www.ncbi.nlm.nih.gov/pubmed/36518236
http://dx.doi.org/10.1097/BS9.0000000000000134

Ejemplares similares